Rifamycin Antimycobacterial
DBCAT003383Therapeutic category
A DrugBank category of 3 drugs. 3 of them are approved.
What you can answer from here — as of November 28, 2022
Which targets do Rifamycin Antimycobacterial share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account